(1R,2S)-1-Amino-2,3-dihydro-1H-inden-2-ol

Suppliers

Names

[ Name ]:
(1R,2S)-1-Amino-2,3-dihydro-1H-inden-2-ol

[Synonym ]:
(1R,2S)-1-amino-2,3-dihydro-1H-inden-2-ol
(1R,2S)-1-Aminoindan-2-ol
MFCD00216656
(1R,2S)-(+)-cis-1-Amino-2-hydroxyindane
1H-Inden-2-ol, 1-amino-2,3-dihydro-, (1R,2S)-
(1R,2S)-(+)-1-Amino-2-indanol
(1R,2S)-(+)-1-Amino-2-hydroxyindan
(1R,2S)-(+)-cis-1-amino-2-indanol
(1R,2S)-1-Amino-2-indanol
Cis-(1R,2S)-1-amino-2-indanol

Chemical & Physical Properties

[ Density]:
1.2±0.1 g/cm3

[ Boiling Point ]:
290.0±40.0 °C at 760 mmHg

[ Melting Point ]:
117-121ºC

[ Molecular Formula ]:
C₉H₁₁NO

[ Molecular Weight ]:
149.19

[ Flash Point ]:
129.2±27.3 °C

[ Exact Mass ]:
149.084061

[ PSA ]:
46.25000

[ LogP ]:
0.43

[ Vapour Pressure ]:
0.0±0.6 mmHg at 25°C

[ Index of Refraction ]:
1.626

MSDS

Click to get detail MSDS

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H315-H319-H335

[ Precautionary Statements ]:
P261-P305 + P351 + P338

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves

[ Hazard Codes ]:
Xn

[ Risk Phrases ]:
R20/21/22;R36/37/38

[ Safety Phrases ]:
S26-S36/37/39

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ HS Code ]:
2922199090

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

DownStream

BIS((3AR,8AS)-8,8A-DIHYDRO-3AH-INDENO[1,2-D]OXAZOL-2-YL)METHANE
(1R,2R)-N-BOC-1-AMINO-2-INDANOL

Customs

[ HS Code ]: 2922199090

[ Summary ]:
2922199090. other amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

Articles

A series of potent HIV-1 protease inhibitors containing a hydroxyethyl secondary amine transition state isostere: synthesis, enzyme inhibition, and antiviral activity.

J. Med. Chem. 35 , 2525, (1992)

A series of HIV-1 protease inhibitors containing a novel hydroxyethyl secondary amine transition state isostere has been synthesized. The compounds exhibit a strong preference for the (R) stereochemis...

Synthesis and antiviral activity of a series of HIV-1 protease inhibitors with functionality tethered to the P1 or P1' phenyl substituents: X-ray crystal structure assisted design.

J. Med. Chem. 35 , 1685, (1992)

By tethering of a polar hydrophilic group to the P1 or P1' substituent of a Phe-based hydroxyethylene isostere, the antiviral potency of a series of HIV protease inhibitors was improved. The optimum e...

HIV-1 protease inhibitors based on hydroxyethylene dipeptide isosteres: an investigation into the role of the P1' side chain on structure-activity.

J. Med. Chem. 35 , 1702, (1992)

A systematic investigation was undertaken to determine the role of the P1' sidechain in a series of hydroxyethylene isostere based inhibitors of HIV-1 protease. Substitution and homologation of the be...

(1R,2S)-1-AMINO-2,3-DIHYDRO-1H-INDEN-2-OL
(1S,2S)-1-AMINO-2,3-DIHYDRO-1H-INDEN-2-OL
(1R,2S)-1-azido-2,3-dihydro-1H-inden-2-ol
(1R,2S)-1-(methylamino)-2,3-dihydro-1H-inden-2-ol
(1R,2S)-1-chloro-2,3-dihydro-1H-inden-2-ol
(1R,2R)-1-AMINO-2,3-DIHYDRO-1H-INDEN-2-OL
4aHydroxya6a({4,8,10atrihydroxya2aoxoa2Habenzo[h]chromena5ayl}methyl)a2Hapyrana2aone
9,10aDioxoa6a(propanoyloxy)a9,10adihydroanthracena1a yl propanoate
Ethinyl estradiol glucuronide
(2S,3aR,5R,12R,16R,17S,17aS)a16aHydroxya2,17adimethoxya5,12adimethyla2H,3H,3aH,4H,5H,6H,11H,12H,14H,15H,16H,17H,17aHafuro[2,3af]oxacyclohexadecanea6,14adione
(3S,6S,8R)a6,9aDihydroxya8amethyla2,4adioxoa 1,2,3,4,5,6,7,8aoctahydrophenanthrena3ayl (2S,4S)a 2,4adimethylhexanoate
1-(2-Hydroxyethyl)-4-methyl-2,6-dioxo-5-{[4-(phenyldiazenyl)phenyl]diazenyl}-1,2,5,6-tetrahydro-3-pyridinecarbonitrile
(5R)-3-[(1R,2R,4aS,6S,8aS)-2-[(1E,3E,6R)-6-hydroxyhepta-1,3-dienyl]-1,3,6-trimethyl-4a,5,6,7,8,8a-hexahydro-2H-naphthalene-1-carbonyl]-5-(hydroxymethyl)pyrrolidine-2,4-dione
Cystoseirol A
6-[[(1S,4'S,5S,6'S,13S,15S)-4',9-dihydroxy-6',10,15-trimethylspiro[6,12,14-trioxatetracyclo[11.3.1.02,11.03,8]heptadeca-2(11),3(8),9-triene-5,2'-oxane]-13-yl]methyl]-2,4-dihydroxy-3-methylbenzaldehyde
(3aR,4S,6R,7R,7aR)-6-[[(1R,5R,7E,9R,10R,11R,12R,13S)-5-[(1E,3E)-6-[(1S,2R)-2-chlorocyclopropyl]hexa-1,3-dien-5-ynyl]-1-hydroxy-9-methoxy-7,10,12-trimethyl-3-oxo-4,15-dioxabicyclo[9.3.1]pentadec-7-en-13-yl]oxy]-7-methoxy-4,7a-dimethyl-3a,4,6,7-tetrahydro-3H-pyrano[3,4-d][1,3]oxazol-2-one

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.